Raqia Therapeutics
Steven is Principal at Binney Street Capital, as well as co-founder and Scientific Advisory Board member of SanaRx Biotherapeutics and NextRNA Therapeutics. He was a scientific consultant at QuantumCyte, Inc. while serving as a scientist at Dana-Farber Cancer Institute. Steven received his Ph.D. in immunology from Mayo Clinic.
This person is not in the org chart
This person is not in any offices
Raqia Therapeutics
Raqia Therapeutics is an exciting startup company developing a transformative chimeric antigen receptor (CAR) technology for immunotherapy. At Raqia Therapeutics, they are motivated to bring life-changing therapy to patients with cancer.